NeoGenomics, Inc. (NEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - NeoGenomics is a healthcare company focused on providing diagnostic testing services for cancer patients, emphasizing the importance of their mission to improve patient outcomes [2][3] - The company has a dedicated team of over 2,500 employees who are passionate about their work and have a personal connection to cancer, which drives their commitment to the mission [2] Patient Impact - NeoGenomics recognizes the significant impact their services have on patients' lives during challenging times, highlighting the responsibility they feel to provide accurate and timely information to patients and their physicians [3] - The company aims to support patients in planning the right course of action based on the diagnostic information they provide [3]